After receiving a drug rejection from the FDA, Woburn-based Replimune Group (Nasdaq: REPL) has informed the state that it ...
The $250 million public-private partnership will transform the former Bracebridge complex previously owned by Bank of America ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results